Shares of Vimian Group AB (publ) (OTCMKTS:VIMGF – Get Free Report) shot up 7.3% during trading on Friday . The stock traded as high as C$3.89 and last traded at C$3.89. 26,000 shares changed hands during mid-day trading, an increase of 87% from the average session volume of 13,867 shares. The stock had previously closed at C$3.62.
Vimian Group AB (publ) Price Performance
The company’s 50 day simple moving average is C$3.63 and its 200 day simple moving average is C$3.43.
Vimian Group AB (publ) Company Profile
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.
Featured Articles
- Five stocks we like better than Vimian Group AB (publ)
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- The Role Economic Reports Play in a Successful Investment Strategy
- These 3 Quirky ETFs May Be Strong Plays in 2025
- Short Selling: How to Short a Stock
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for Vimian Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vimian Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
